Skip to Main content Skip to Navigation
Journal articles

Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.

Abstract : Various iodo-acridone and acridine carboxamides have been prepared and evaluated as agents for targeted radionuclide and/or chemotherapy for melanoma, due to their structural similarity to benzamides which are known to possess specific affinity for melanin. Three of these carboxamides selected for their in vitro cytotoxic properties were radioiodinated with [125I]NaI at high specific activity. Biodistribution studies carried out in B16F0 murine melanoma tumour-bearing mice highlighted that acridone 8f and acridine 9d, presented high, long-lasting tumour concentrations together with an in vivo kinetic profile favourable to application in targeted radionuclide therapy.
Complete list of metadatas

Cited literature [39 references]  Display  Hide  Download

https://hal.uca.fr/hal-01494523
Contributor : Philippe Auzeloux <>
Submitted on : Monday, January 8, 2018 - 2:36:30 PM
Last modification on : Thursday, June 11, 2020 - 3:20:22 AM

Identifiers

Collections

Citation

Nicolas Desbois, Maryline Gardette, Janine Papon, Pierre Labarre, Aurélie Maisonial, et al.. Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.. Bioorganic and Medicinal Chemistry, Elsevier, 2008, 16 (16), pp.7671-7690. ⟨10.1016/j.bmc.2008.07.015⟩. ⟨hal-01494523⟩

Share

Metrics

Record views

218